Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at ORTHOPEDIATRICS CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ORTHOPEDIATRICS CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ORTHOPEDIATRICS CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Fred L. Hite
Chief Operating Officer and Chief Financial Officer
Total Cash $778,219 Equity $1,244,700 Other $13,200 Total Compensation $2,036,119
Daniel J. Gerritzen
Executive Vice President (Legal), General Counsel, and Secretary
Total Cash $524,795 Equity $813,909 Other $13,200 Total Compensation $1,351,904
David R. Bailey
President and Chief Executive Officer
Total Cash $864,688 Equity $1,843,952 Other $13,200 Total Compensation $2,721,840
Gregory A. Odle
President of Scoliosis
Total Cash $524,795 Equity $813,909 Other $13,200 Total Compensation $1,351,904
Joseph W. Hauser
President of Trauma and Deformity Correction
Total Cash $524,795 Equity $813,909 Other $13,200 Total Compensation $1,351,904
For its 2023 fiscal year, ORTHOPEDIATRICS CORP, listed the following board members on its annual proxy statement to the SEC.
Bryan W. Hughes Total Cash $190,000
David R. Pelizzon Total Cash $180,000
George Dyer Total Cash $135,000
Harald Ruf Total Cash $180,000
Jimmy D. McDonald Total Cash $180,000
Kevin L. Unger Total Cash $22,500
Marie C. Infante Total Cash $185,000
Samuel D. Riccitelli Total Cash $180,000
Terry D. Schlotterback Total Cash $185,000

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.